Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DefenAge
Carlsbad, California, United Statesdefenage.com ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
DefenAge is a technology-driven cosmeceutical company that specializes in regenerative skincare through the use of synthetic defensin peptides. The company's proprietary Age-Repair Defensins technology is designed to specifically target and activate LGR6+ stem cells in the skin, which are responsible for creating new, youthful basal cells. Unlike traditional growth factors or retinol, DefenAge's mechanism focuses on triggering the body's natural regenerative response to improve skin texture, tone, and visible signs of aging. Their product line is backed by extensive clinical studies and is primarily distributed through dermatologists, plastic surgeons, and aesthetic physicians.
- Therapeutic areas
- Dermatology
- Modalities
- Peptides
- Industry
- Non-Drug Biotech
Beyond the preview
Go deeper on DefenAge.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DefenAge.